Ophthalmic Formulations: Safety and Efficacy of VEGF-neutralizing Drug

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

View Supplement

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

View Supplement

One to Watch: Archana A. Nair, MD, MS

Editorially independent supported by Abbvie and Regenxbio

View Insert

Complex Retinal Detachment Repair Facilitated by TissueBlue™

Supported by Zeiss

View Insert